Biohit Oyj

Biohit Oyj B-shares Subscribed with Stock Options II 201

Biohit Oyj expands the distribution of Acetium® lozenge to dental care

Modern colorectal cancer screening test on the market from Finland

BIOHIT GROUP INTERIM REPORT Q1-2015

European Parliament urges the Commission to immediately ask the European Food Safety Authority (EFSA) to re-evaluate the use of acetaldehyde

Mekalasi Oy to distribute Biohit Quick Tests in Finland

Constitutive meeting of Biohit Oyj’s Board of Directors

Decisions of the Annual General Meeting of Biohit Oyj

Acetaldehyde safety concerns

Effortless accuracy with Biohit Quick Test Reader

Acetaldehyde – a major pathophysiologic factor in gastric carcinogenesis

Recommendations for detection of gastric cancer risk and monitoring of the cancer precursors

Biohit Oyj B-shares Subscribed with Stock Options II 2013

Publication of Biohit Oyj Annual Report 2014

Biohit and Gulf Drug to sign a distributor agreement

CORRECTION: NOTICE OF BIOHIT OYJ’S ANNUAL GENERAL MEETING

NOTICE OF BIOHIT OYJ’S ANNUAL GENERAL MEETING

Biohit and Oriola to distribution agreement

BIOHIT GROUP FINANCIAL STATEMENT RELEASE 2014

BIOHIT ColonView is the best colorectal cancer screening test on the market

Biohit Oyj and Akeso to sign an Acetium distribution agreement in Russia

Biohit and Ympyrätalo Pharmacy to co-operation

Biohit and Eurobio to sign a distributor agreement

Biohit and Doctagon to co-operation

Biohit Oyj B-shares Subscribed with Stock Options II 2013

Biohit’s Financial Reporting and Annual General Meeting in 2015

Biohit re-launches ColonView – test for colorectal cancer screening

Changes to Biohit Oyj’s management

Biohit Oyj B-shares Subscribed with Stock Options II 2013

BIOHIT GROUP INTERIM REPORT Q3/2014